Updated 2026-06-17 · 5,726 providers · 47 states
GLP-1 weight loss medications — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are offered at 5,726 med spas across 47 states, typically $200–$1,500 per month. They are FDA-approved injectable medications for medical weight management, usually paired with nutrition and lifestyle coaching under clinical supervision.
GLP-1 receptor agonists are FDA-approved injectable medications that reduce appetite and slow digestion to support weight loss. The two most common are semaglutide (sold as Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). At med spas they are prescribed as part of a medically supervised program, often alongside nutrition and lifestyle coaching.
Medically supervised GLP-1 programs typically run $200–$1,500 per month, depending on the medication (brand-name vs. compounded), dose, and whether labs and coaching are included. Compounded semaglutide is usually cheaper than brand-name Ozempic/Wegovy.
Semaglutide is the active ingredient; Ozempic and Wegovy are brand-name semaglutide. Tirzepatide is a different molecule sold as Mounjaro and Zepbound. Med spas may offer brand-name or compounded versions — ask which you're being prescribed.
A GLP-1 program should be overseen by a licensed medical provider (MD, DO, NP, or PA), include an intake evaluation and follow-up, and be transparent about whether the medication is brand-name or compounded. Avoid programs that prescribe without any medical evaluation.
Ranked by patient rating × review volume. Find more in any city guide.
Not medical advice. This page is informational. GLP-1 medications are prescription drugs with risks and side effects; only a licensed medical provider can determine whether they are appropriate for you. Always consult a qualified clinician. See our methodology.